News: $ENDP Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy
DUBLIN , Sept. 30, 2019 /PRNewswire/ -- Endo International plc ("Endo") (NASDAQ: ENDP) today announced the successful culmination of two litigation matters before the U.S. District Court for the District of Columbia regarding the unlawful compounding of vasopressin from bulk dru...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.